T. Rowe Price Associates’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | – | Sell |
-535,315
| Closed | -$2.46M | – | 2634 |
|
2020
Q2 | $2.46M | Sell |
535,315
-55,768
| -9% | -$256K | ﹤0.01% | 1492 |
|
2020
Q1 | $1.96M | Sell |
591,083
-122,199
| -17% | -$404K | ﹤0.01% | 1500 |
|
2019
Q4 | $4.36M | Sell |
713,282
-37,596
| -5% | -$230K | ﹤0.01% | 1418 |
|
2019
Q3 | $3.13M | Sell |
750,878
-45,358
| -6% | -$189K | ﹤0.01% | 1455 |
|
2019
Q2 | $10.4M | Buy |
796,236
+144,535
| +22% | +$1.9M | ﹤0.01% | 1307 |
|
2019
Q1 | $6.2M | Buy |
651,701
+600
| +0.1% | +$5.71K | ﹤0.01% | 1378 |
|
2018
Q4 | $2.01M | Buy |
+651,101
| New | +$2.01M | ﹤0.01% | 1557 |
|